129 related articles for article (PubMed ID: 6349709)
21. Comparison of the biodistribution of gadolinium-153 DTPA and technetium-99m DTPA in rats.
Prato FS; Wisenberg G; Marshall TP; Uksik P; Zabel P
J Nucl Med; 1988 Oct; 29(10):1683-7. PubMed ID: 3049959
[TBL] [Abstract][Full Text] [Related]
22. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
Vilcek S; Kalincák M; Machán V
Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
[TBL] [Abstract][Full Text] [Related]
23. Binding and diffusion characteristics of 14C EDTA and 99mTc DTPA in respiratory tract mucus glycoprotein from patients with chronic bronchitis.
Cheema MS; Groth S; Marriott C
Thorax; 1988 Sep; 43(9):669-73. PubMed ID: 3143162
[TBL] [Abstract][Full Text] [Related]
24. Attachment of 99mTc to lipid vesicles containing the lipophilic chelate dipalmitoylphosphatidylethanolamine-DTTA.
Ahkong QF; Tilcock C
Int J Rad Appl Instrum B; 1992 Nov; 19(8):831-40. PubMed ID: 1428912
[TBL] [Abstract][Full Text] [Related]
25. 99mTc-DTPA clearance in bullous emphysema.
Antonelli Incalzi R; Maini CL; Bonetti MG; Pistelli R; Valle G
Nuklearmedizin; 1985 Aug; 24(4):180-4. PubMed ID: 3909111
[TBL] [Abstract][Full Text] [Related]
26. Lung clearance of inhaled 99mTc-DTPA in the dog.
Oberdörster G; Utell MJ; Weber DA; Ivanovich M; Hyde RW; Morrow PE
J Appl Physiol Respir Environ Exerc Physiol; 1984 Aug; 57(2):589-95. PubMed ID: 6381442
[TBL] [Abstract][Full Text] [Related]
27. Detection of diffuse glomerular lesions in rats: II. Comparison of indium-111 cationic small macromolecules with technetium-99m DTPA.
McAfee JG; Thomas FD; Subramanian G; Schneider RD; Lyons B; Roskopf M; Zapf-Longo C; Whaley D
J Nucl Med; 1986 Apr; 27(4):513-20. PubMed ID: 2423665
[TBL] [Abstract][Full Text] [Related]
28. A novel liposome radiolabeling method using 99mTc-"SNS/S" complexes: in vitro and in vivo evaluation.
Bao A; Goins B; Klipper R; Negrete G; Mahindaratne M; Phillips WT
J Pharm Sci; 2003 Sep; 92(9):1893-904. PubMed ID: 12950007
[TBL] [Abstract][Full Text] [Related]
29. Estimation of extracellular fluid volume from plasma clearance on technetium-99m DTPA by a single-injection, two-sample method.
Russell CD; Bischoff PG; Rowell KL; Lloyd LK; Dubovsky EV
J Nucl Med; 1988 Feb; 29(2):255-8. PubMed ID: 3279167
[TBL] [Abstract][Full Text] [Related]
30. Cigarette smoke induced changes in rat pulmonary clearance of 99mTcDTPA. A comparison of particulate and gas phases.
Minty BD; Royston D
Am Rev Respir Dis; 1985 Dec; 132(6):1170-3. PubMed ID: 3907442
[TBL] [Abstract][Full Text] [Related]
31. Specific accumulation of technetium-99m radiolabelled, negative liposomes in the inflamed paws of rats with adjuvant induced arthritis: effect of liposome size.
Love WG; Amos N; Kellaway IW; Williams BD
Ann Rheum Dis; 1989 Feb; 48(2):143-8. PubMed ID: 2930265
[TBL] [Abstract][Full Text] [Related]
32. Changes in pulmonary clearance of technetium labelled DTPA during haemodialysis.
Belcher NG; Rees PJ
Thorax; 1986 May; 41(5):381-5. PubMed ID: 3529481
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of liposome-entrapped radioactive tracers as scanning agents. Part 1: Organ distribution of liposome (99mTc-DTPA) in mice.
Caride VJ; Taylor W; Cramer JA; Gottschalk A
J Nucl Med; 1976 Dec; 17(12):1067-72. PubMed ID: 993839
[TBL] [Abstract][Full Text] [Related]
34. Intravenous technetium-99m labelled PEG-liposomes in horses: a safety and biodistribution study.
Underwood C; van Eps AW; Ross MW; Laverman P; van Bloois L; Storm G; Schaer TP
Equine Vet J; 2012 Mar; 44(2):196-202. PubMed ID: 21696436
[TBL] [Abstract][Full Text] [Related]
35. Technetium-99m-labeled liposomes to image experimental colitis in rabbits: comparison with technetium-99m-HMPAO-granulocytes and technetium-99m-HYNIC-IgG.
Dams ET; Oyen WJ; Boerman OC; Storm G; Laverman P; Koenders EB; van der Meer JW; Corstens FH
J Nucl Med; 1998 Dec; 39(12):2172-8. PubMed ID: 9867164
[TBL] [Abstract][Full Text] [Related]
36. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies.
Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Abra RM; Stewart JS
Br J Cancer; 2000 Jul; 83(2):232-8. PubMed ID: 10901376
[TBL] [Abstract][Full Text] [Related]
37. Dual pathway clearance of 99mTc-DTPA from the bronchial mucosa.
Bennett WD; Ilowite JS
Am Rev Respir Dis; 1989 May; 139(5):1132-8. PubMed ID: 2653148
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the renal clearance of technetium-99m PAHIDA in dogs.
Summerville DA; Packard AB; Bartynski B; Lim KS; Chervu LR; Treves ST
J Nucl Med; 1987 May; 28(5):907-9. PubMed ID: 3553465
[TBL] [Abstract][Full Text] [Related]
39. Prospective comparative study of technetium-99m-WBCs and indium-111-granulocytes for the examination of patients with inflammatory bowel disease.
Arndt JW; van der Sluys Veer A; Blok D; Griffoen G; Verspaget HW; Lamers CB; Pauwels EK
J Nucl Med; 1993 Jul; 34(7):1052-7. PubMed ID: 8315478
[TBL] [Abstract][Full Text] [Related]
40. Tumor imaging with technetium-99m-DTPA encapsulated in RES-avoiding liposomes.
Oku N; Namba Y; Takeda A; Okada S
Nucl Med Biol; 1993 May; 20(4):407-12. PubMed ID: 8504283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
